Earnings, deals and disclosures from Japan's listed trading houses & wholesale companies, in English.
A three-party deal with BIOLAB and AIDEN LAB JAPAN gives the group exclusive sales and marketing rights in Japan for the South Korean femcare brand, with full-scale sales planned for the second half of the year ending January 2027. Direct, wholesale and online channels are planned, but pricing and the final Japan lineup are still undisclosed.
The company will absorb wholly owned subsidiary SPZ on Oct. 1, saying changing customer needs and market conditions call for resource optimization and a rebuilt operating structure. No consideration is involved and Solekia says the earnings impact should be minor.
Sales rose 5.1% to ¥286,172 million and operating profit increased 10.2% to ¥21,037 million in the six months to April, while net profit attributable to owners rose 15.7% to ¥16,501 million. Management nevertheless left full-year earnings guidance and its ¥32.00 dividend forecast unchanged.
First-quarter sales rose 10.7% to ¥67.844 billion and operating profit rose 13.8% to ¥2.052 billion, with the distributor business doing most of the heavy lifting. May sales then ran at 109.9% of the prior-year month, while cash-and-carry growth stayed much softer.
First-quarter sales rose to ¥1.801 billion and operating profit turned positive, but a ¥31.16 million loan-loss allowance and tax expense left a ¥36 million net loss. Separately, the company disclosed a post-quarter cash outflow of about ¥45 million after a false remittance instruction by a third party posing as company personnel.
Beauty Garage lifted revenue 13.3% to ¥38.2 billion in the year to April 2026, but operating profit fell 4.8% to ¥1.52 billion and operating cash flow dropped to ¥553 million from ¥1.42 billion. Management tied much of the squeeze to opening and stabilising the new Kashiwa fulfillment center while old and new logistics sites ran in parallel, and the presentation put the negative profit impact at roughly ¥580 million. The board still kept the year-end dividend at ¥8 a share, taking the full-year payout to ¥16. The company's rebound case depends on that warehouse behaving less like a construction site and more like an asset.
Bitcoin Japan wants shareholders on June 29 to keep CEO Phillip Lord in place, add Masato Mori and three outside directors, and approve a revamped long-term incentive package built around revised RSUs, new PSUs and paid stock options. The package comes with multi-year transfer restrictions, malus and clawback terms, and stepped share-price hurdles, while the company also wants more flexibility to expand into new business lines and set up a Singapore subsidiary for AI infrastructure investments. Shareholders are being asked to approve a framework first and the finer points later.
The company raised full-year sales guidance to JPY 154 billion from JPY 144 billion and net profit to JPY 8.5 billion from JPY 7.7 billion, saying demand from semiconductor manufacturing equipment and machine-tool customers recovered faster than expected. It also raised the annual dividend plan to JPY 160 a share from JPY 150, though construction and electrical-distribution demand still faces project delays tied to cost inflation and labor shortages.
Revenue guidance for the year to July rises to ¥421 billion from ¥418 billion and the planned year-end dividend to ¥72 a share, helped by GIGA School replacements and large education-network projects. Operating profit stays at ¥15.4 billion because some local-government system work slipped into next year and the company booked ¥749 million of warranty provisions for future support.
Toyota Tsusho's self-tender turned into an ownership reset. Shareholders tendered 118,109,134 shares against a planned purchase amount of 118,095,402, so the company used pro-ration and ended up buying 118,095,432 shares. The offer was only marginally oversubscribed, but still large enough to matter. Why it matters: Toyota Tsusho says the holder named as Toyoda Jidoshoki goes from 11.19% of voting rights to effectively zero once settlement begins on June 24. This was not just cash spent on a buyback; it redraws the disclosed ownership map.
On June 1, 32,000 first adjustable-price warrants were exercised, creating 3.2 million new shares and using 22.78% of the original issue. After that burst, 26,397 warrants remained outstanding, equivalent to 2,639,700 shares, though the company's separate May status notice shows a different month-end balance and leaves the paperwork looking untidier than investors would prefer.
The move: after a record year to March 2026, Sangetsu set a tougher medium-term task for overseas operations, targeting sales of 542.0 and operating profit of 30.0 by March 2030 on the company's disclosed ¥100 million scale. The catch: next year's operating profit guide slips as wages, logistics and growth investment rise, and Middle East-related effects are not yet quantified.
Japan Lifeline plans to rename itself JLL Med from March 1, 2027, subject to shareholder approval in June 2026, while also adding an executive-officer framework and rewriting its articles to separate board supervision from day-to-day execution.